Exagen inc. to participate in the keybanc capital markets life sciences & medtech investor forum

Carlsbad, calif., march 08, 2024 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced its participation in the keybanc capital markets life sciences & medtech investor forum, which takes place virtually march 19-20, 2024. john aballi, exagen's president and chief executive officer, and kamal adawi, exagen's chief financial officer, will participate in one-on-one meetings with investors and a fireside chat on wednesday, march 20, at 1:30 pm et.
XGN Ratings Summary
XGN Quant Ranking